Public disclosure of inside information according to article 17 MAR

Biofrontera AG: Biofrontera AG announces revised strategy

Leverkusen, Germany (pta018/20.02.2024/13:45 UTC+1)

Biofrontera AG today entered into an agreement with Biofrontera Inc. to modify the business relationship between the two companies. Biofrontera AG will focus on capitalizing its existing projects and know-how, while research and development will no longer be a core part of its activities. This revised strategy and the amended agreement with Biofrontera AG's largest customer, Biofrontera Inc., will have a significant impact on the structure of revenues and costs, both of which will be reduced. Biofrontera AG will provide new guidance for 2024 in due course.


Emitter: Biofrontera AG
Hemmelrather Weg 201
51377 Leverkusen
Contact Person: Investor Relations
Phone: +49 (0) 214 87 63 20
ISIN(s): DE0006046113 (Share)
Stock Exchange(s): Regulated Market in Dusseldorf, Frankfurt; Free Market in Berlin, Munich, Stuttgart, Tradegate